Bioptimus hits major funding milestone, unveils plans for transformative biology model
Bioptimus, a Paris-based leader in artificial intelligence innovation, has reached a remarkable funding milestone of $76 million, underscoring its potential to transform biological research. The ... Read More
Gradient Denervation raises €14m for pulmonary hypertension treatment
Gradient Denervation Technologies has successfully closed a €14 million Series A financing round to support the clinical development of its ultrasound-based catheter device for pulmonary ... Read More
French biotech company Amolyt Pharma Series C round fetches $138m
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C equity financing round led by Sofinnova Partners ... Read More